[{"address1": "3580 CARMEL MOUNTAIN ROAD", "address2": "SUITE 200", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1040", "fax": "858 614 7007", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is headquartered in San Diego, California.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barry D. Quart Pharm.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 547466, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David L. Szekeres J.D.", "age": 50, "title": "President", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 409305, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Peraza CPA", "age": 47, "title": "Vice President of Finance", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 210889, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Cohn J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 60, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul  Collazo Ph.D.", "age": 57, "title": "VP & Global Head of Medical Affairs", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srikanth  Pendyala M.D.", "title": "Senior Vice President of Clinical Development(Consultant)", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly J. Manhard", "age": 64, "title": "Executive VP & Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.843, "open": 0.85, "dayLow": 0.7334, "dayHigh": 0.88, "regularMarketPreviousClose": 0.843, "regularMarketOpen": 0.85, "regularMarketDayLow": 0.7334, "regularMarketDayHigh": 0.88, "payoutRatio": 0.0, "beta": -0.216, "forwardPE": -3.6959999, "volume": 103652, "regularMarketVolume": 103652, "averageVolume": 95133, "averageVolume10days": 370650, "averageDailyVolume10Day": 370650, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 40914128, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 2.08, "priceToSalesTrailing12Months": 1.5716256, "fiftyDayAverage": 0.80076, "twoHundredDayAverage": 1.072415, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -52615864, "profitMargins": -0.60030997, "floatShares": 14161648, "sharesOutstanding": 55349200, "sharesShort": 5404, "sharesShortPriorMonth": 46660, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.41089, "heldPercentInstitutions": 0.44764, "shortRatio": 0.21, "shortPercentOfFloat": 0.0002, "impliedSharesOutstanding": 55349200, "bookValue": 1.665, "priceToBook": 0.44396397, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15628000, "trailingEps": -0.28, "forwardEps": -0.2, "enterpriseToRevenue": -2.021, "enterpriseToEbitda": 2.414, "52WeekChange": -0.4525926, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.7392, "targetHighPrice": 8.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 93708000, "totalCashPerShare": 1.693, "ebitda": -21792000, "totalDebt": 178000, "quickRatio": 11.198, "currentRatio": 11.458, "totalRevenue": 26033000, "debtToEquity": 0.193, "revenuePerShare": 0.472, "returnOnAssets": -0.12274, "returnOnEquity": -0.16139, "grossProfits": 26033000, "freeCashflow": -23097500, "operatingCashflow": -23612000, "grossMargins": 1.0, "ebitdaMargins": -0.83709, "operatingMargins": -14.81168, "financialCurrency": "USD", "symbol": "CNTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "shortName": "Connect Biopharma Holdings Limi", "fiftyTwoWeekLowChangePercent": 0.44941178, "fiftyTwoWeekRange": "0.51 - 2.08", "fiftyTwoWeekHighChange": -1.3407999, "fiftyTwoWeekHighChangePercent": -0.64461535, "fiftyTwoWeekChangePercent": -45.259262, "earningsTimestamp": 1743426000, "earningsTimestampStart": 1743426000, "earningsTimestampEnd": 1743426000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.2, "epsCurrentYear": -0.975, "priceEpsCurrentYear": -0.7581538, "fiftyDayAverageChange": -0.061559975, "fiftyDayAverageChangePercent": -0.07687694, "twoHundredDayAverageChange": -0.333215, "twoHundredDayAverageChangePercent": -0.3107146, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1744933814, "regularMarketTime": 1744920000, "exchange": "NGM", "messageBoardId": "finmb_706016439", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -12.3132, "regularMarketPrice": 0.7392, "longName": "Connect Biopharma Holdings Limited", "postMarketChangePercent": 0.0, "postMarketPrice": 0.7392, "postMarketChange": 0.0, "regularMarketChange": -0.1038, "regularMarketDayRange": "0.7334 - 0.88", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 95133, "fiftyTwoWeekLowChange": 0.2292, "marketState": "CLOSED", "displayName": "Connect Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]